Allient (ALNT) After Falling Sales And EPS What Is The Valuation Narrative
Fresh scrutiny of Allient (ALNT) has been triggered by reports of declining sales and earnings per share over the past two years, along with persistently low returns on capital that are shaping the current investment debate.
See our latest analysis for Allient.
Despite the pressure on Allient’s fundamentals, the stock has kept strong momentum, with a year to date share price return of 57.36% and a 1 year total shareholder return of 130.59%, even after an 11.33% decline over the past month.
If Allient’s moves have caught your attention, this is a good moment to widen your search and check out 36 robotics and automation stocks
For Allient, the recent surge in the share price sits awkwardly alongside weaker sales, lower earnings per share and soft returns on capital. Is the current valuation now driven more by enthusiasm than by the underlying business?
Most Popular Narrative: 18.5% Overvalued
Against a last close of $87.46, the most followed Allient narrative points to a fair value of $73.80, which puts current enthusiasm under the microscope.
Expectations for margin and earnings improvement could face headwinds from rising compliance costs, supply chain risks, and challenges in executing profitable expansion strategies.
Curious what is baked into that fair value gap? The narrative leans on steady revenue gains, higher profitability and a future earnings multiple that assumes cleaner execution. The exact mix of growth, margins and valuation is where the real story sits.
Result: Fair Value of $73.80 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Allient could still surprise the skeptics if margin gains from its Simplify to Accelerate NOW program stick and higher value aerospace and defense exposure proves more resilient than expected.
Find out about the key risks to this Allient narrative.
Next Steps
With mixed sentiment around Allient, this is a good time to move quickly, review the full picture yourself, and weigh both risks and rewards. You can start by checking the 2 key rewards and 1 important warning sign
Looking for more investment ideas beyond Allient?
If Allient has sharpened your focus, do not stop here. Use the Simply Wall St screener to spot other stocks that could better fit your investing goals.
- Target potential mispricings and compare alternatives by scanning 55 high quality undervalued stocks that may offer a more attractive balance of quality and price.
- Strengthen your income focus by reviewing 9 dividend fortresses that combine higher yields with an emphasis on durability.
- Prioritise resilience by evaluating 81 resilient stocks with low risk scores that aim to keep overall risk in check while you build your portfolio.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com